Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.1068 per EA under NDC 00527241532. Its NADAC has been published 119 times since Aug 10, 2022.
FDA first approved this application on Aug 21, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Lannett Company Inc.NDC
00527241532
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208652FDA Approved
8/21/2017
TE Code
AB3
On Market Since
1/8/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 119 times since Aug 10, 2022, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1068 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0978 (Jul 17, 2024) |
| Median price | $0.1048 |
| Average price | $0.1068 |
| Largest weekly change | -15.1% (Apr 17, 2024) |
| Weeks tracked | 119 |
| Tracking since | Aug 10, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+5.4%
5Y
N/A
All
-7.5%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Lannett Company Inc., is $0.1068 per EA (NDC 00527241532), effective Nov 13, 2024.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 7.5%. It has been tracked across 119 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Aug 10, 2022, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0978 (Jul 17, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1048 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0785 per EA — about 27% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 00527241532) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.